Residents

Assembly Biosciences

Assembly Biosciences

Assembly Biosciences is an infectious disease-focused biopharmaceutical company developing novel treatments for hepatitis B virus (HBV) infection and C. difficile-associated diarrhea (CDAD). Both programs have breakthrough potential to provide better cure rates for these highly debilitating infectious diseases. Assembly and its employees are committed to advancing science and enhancing the health and well-being of patients. This commitment, along with a vibrant team culture, drives our efforts to develop and commercialize novel approaches to treating HBV and CDAD.

Area of focus: 
Infectious Diseases & Vaccines
Commencement date: 
10/08/2013

Share